Mayo Clinic Labs @Work: Katie Perry - Insights
Katie Perry’s work as a supervisor for the Mayo Lab Inquiry call center helps ensure that clients get the information they need, when they need it, and smooths the way for tests to be completed without delay.
MCL @Work: Adam Stewart - Insights
In spring of 2022, Adam Stewart joined Mayo Clinic’s Blood Donor Program as a marketing and recruitment coordinator. He enjoys and finds great purpose in his work because he loves to see members of his local community donate blood and help...
Reversing a dire disorder: Lorinda McKinley - Insights
Advanced testing at Mayo Clinic Laboratories that confirmed a diagnosis of myasthenia gravis put Lorinda McKinley on the road to renewed health after she nearly lost it all to the rare autoimmune disease.
MCL @Work: Brie LaJoye - Insights
Brie LaJoye began her career with Mayo Clinic in 2018 as an intern and has been with the organization for nearly six years. She currently works as a Laboratory information system (LIS) technical specialist, managing lab instrumentation,...
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
10th Annual Forensic Science Symposium - Insights
Mayo Clinic's 10th Annual Forensic Science Symposium will cover a wide variety of topics, ranging from forensic odontology to traffic accident injuries. There will also be a focus on fatal accident prevention, all-terrain vehicle (ATV) use...
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
New tests launched in October - Insights
In October 2021, Mayo Clinic Laboratories announced eleven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...